Skip to content

Clinical trials

Lymphoma, Large B-Cell, Diffuse trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Country / region: Italy Clear all

161 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20033
20042
20057
20063
20072
20081
20094
20102
20118
20126
20138
20143
20155
201611
20174
20184
201911
202012
20219
202214
20239
20246
20256
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70
Recruiting27
Terminated26
Active, not recruiting20
Unknown status11
Not yet recruiting4
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione Italiana Linfomi - ETS17
Novartis Pharmaceuticals11
Fred Hutchinson Cancer Center8
Hoffmann-La Roche8
Celgene7
Incyte Corporation6
Merck Sharp & Dohme LLC6
European Organisation for Research and Treatment of Cancer - EORTC5
Genmab5
ADC Therapeutics S.A.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse161
Lymphoma, Non-Hodgkin53
Lymphoma, Follicular44
Lymphoma, Mantle-Cell36
Lymphoma31
Leukemia, Lymphocytic, Chronic, B-Cell30
Lymphoma, B-Cell, Marginal Zone28
Recurrence27
Burkitt Lymphoma24
Precursor Cell Lymphoblastic Leukemia-Lymphoma21

Trials

Showing 76 to 100 of 161. Each trial links to its page on Pharma Observatory.

61 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.